US 7855202
Imidazopyridine derivatives as A2B adenosine receptor antagonists
granted A61PA61P1/00A61P11/00
Quick answer
US patent 7855202 (Imidazopyridine derivatives as A2B adenosine receptor antagonists) held by Laboratories Almirall, S.A. expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Laboratories Almirall, S.A.
- Grant date
- Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/00, A61P11/00, A61P11/06, A61P11/08